CD19 REGULATES THE DEVELOPMENT OF BLEOMYCIN-INDUCED PULMONARY FIBROSIS
Publication
, Journal Article
Komura, K; Yanaba, K; Horikawa, M; Ogawa, F; Fujimoto, M; Tedder, TF; Varga, J; Sato, S
Published in: Clinical and Experimental Rheumatology
2010
Duke Scholars
Published In
Clinical and Experimental Rheumatology
ISSN
0392-856X
Publication Date
2010
Volume
28
Issue
2
Start / End Page
S74 / S74
Related Subject Headings
- Arthritis & Rheumatology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Komura, K., Yanaba, K., Horikawa, M., Ogawa, F., Fujimoto, M., Tedder, T. F., … Sato, S. (2010). CD19 REGULATES THE DEVELOPMENT OF BLEOMYCIN-INDUCED PULMONARY FIBROSIS. Clinical and Experimental Rheumatology, 28(2), S74–S74.
Komura, K., K. Yanaba, M. Horikawa, F. Ogawa, M. Fujimoto, T. F. Tedder, J. Varga, and S. Sato. “CD19 REGULATES THE DEVELOPMENT OF BLEOMYCIN-INDUCED PULMONARY FIBROSIS.” Clinical and Experimental Rheumatology 28, no. 2 (2010): S74–S74.
Komura K, Yanaba K, Horikawa M, Ogawa F, Fujimoto M, Tedder TF, et al. CD19 REGULATES THE DEVELOPMENT OF BLEOMYCIN-INDUCED PULMONARY FIBROSIS. Clinical and Experimental Rheumatology. 2010;28(2):S74–S74.
Komura, K., et al. “CD19 REGULATES THE DEVELOPMENT OF BLEOMYCIN-INDUCED PULMONARY FIBROSIS.” Clinical and Experimental Rheumatology, vol. 28, no. 2, 2010, pp. S74–S74.
Komura K, Yanaba K, Horikawa M, Ogawa F, Fujimoto M, Tedder TF, Varga J, Sato S. CD19 REGULATES THE DEVELOPMENT OF BLEOMYCIN-INDUCED PULMONARY FIBROSIS. Clinical and Experimental Rheumatology. 2010;28(2):S74–S74.
Published In
Clinical and Experimental Rheumatology
ISSN
0392-856X
Publication Date
2010
Volume
28
Issue
2
Start / End Page
S74 / S74
Related Subject Headings
- Arthritis & Rheumatology
- 1103 Clinical Sciences